Living donor liver transplantation for hepatocellular carcinoma in Seoul National University.

Journal: Hepatobiliary surgery and nutrition
Published Date: Dec 1, 2016

Abstract

BACKGROUND: Liver transplantation is an effective treatment modality for hepatocellular carcinoma (HCC). Due to deceased organ shortage, living donor liver transplantation (LDLT) accounts for the majority of liver transplants in Korea. The aim of this study is to evaluate the recent trend of LDLT for HCC, and to suggest guidelines and criteria for selecting the appropriate candidates for LDLT.

Authors

  • Suk Kyun Hong
    Department of Surgery, College of Medicine, Seoul National University, Seoul 110-744, Korea.
  • Kwang-Woong Lee
    Department of Surgery, College of Medicine, Seoul National University, Seoul 110-744, Korea.
  • Hyo-Sin Kim
    Department of Surgery, College of Medicine, Seoul National University, Seoul 110-744, Korea.
  • Kyung Chul Yoon
    Department of Surgery, College of Medicine, Seoul National University, Seoul 110-744, Korea.
  • Nam-Joon Yi
    Department of Surgery, College of Medicine, Seoul National University, Seoul 110-744, Korea.
  • Kyung-Suk Suh
    Department of Surgery, Seoul National University College of Medicine, Seoul, Korea.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals